short ragweed pollen allergen Report issue

Allergen Approved FDA
AACT PubChem

Active Ingredient History

NOW
  • Now
Ambrosia artemisiifolia, with the common names common ragweed, annual ragweed, and low ragweed, is a species of the genus Ambrosia native to regions of the Americas.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

ambrosia | ambrosia artemisiifolia allergen | ambrosia artemisiifolia allergen extract | pollens - weeds and garden plants, ragweed, short ambrosia artemisiifolia | ragweed | ragweed allergen | ragwitek | short ragweed pollen allergen extract | short ragweed pollen allergenic extract | slit one ragweed | toleromune ragweed

Organizations (34)

Research & Development (32)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (4)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (12)

Approved Indications (1)


 

Hypersensitivity, Immediate (approved 1924)

Experimental Indications - Clinical Trial Phases 1-4 (12)


 

Allergy and Immunology (Phase 2)

Arthritis, Rheumatoid (Phase 1)

Asthma (Phase 2)

Conjunctivitis (Phase 2/Phase 3)

Conjunctivitis, Allergic (Phase 1)

Hypersensitivity (Phase 4)

Hypersensitivity, Immediate (Phase 3)

Lymphoma, Non-Hodgkin (Phase 1/Phase 2)

Pancreatic Neoplasms (Phase 1)

Rhinitis (Phase 2)

Rhinitis, Allergic (Phase 3)

Rhinitis, Allergic, Seasonal (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 30
  • # of Trial Organizations: 32

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue